Literature DB >> 21224044

Evidence for a functional role of the molecular chaperone clusterin in amyloidotic cardiomyopathy.

Michael J Greene1, Flora Sam, Pamela T Soo Hoo, Rupesh S Patel, David C Seldin, Lawreen H Connors.   

Abstract

Molecular chaperones, including the extracellular protein clusterin (CLU), play a significant role in maintaining proteostasis; they have a unique capacity to bind and stabilize non-native protein conformations, prevent aggregation, and keep proteins in a soluble folding-competent state. In this study, we investigated amyloid-infiltrated cardiac tissue for the presence of CLU and measured serum levels of CLU in patients with and without amyloidotic cardiomyopathy (CMP). Cardiac tissues containing amyloid deposits composed of either transthyretin (TTR) or Ig light chain from nine patients with amyloidotic CMP were examined for the presence of CLU using immunohistochemical techniques. CLU staining coincided with the extracellular myocardial amyloid deposits in tissues from patients with familial TTR, senile systemic, and Ig light chain amyloidosis. The association of CLU with cardiac amyloid deposits was confirmed by immunogold electron microscopy. Serum concentrations of CLU were measured in familial TTR, senile systemic, and Ig light chain amyloidosis patient groups and compared with both age-matched healthy controls and with patients with CMP unrelated to amyloid disease. Subset analysis of disease cohorts, based on cardiac involvement, indicated that decreased serum CLU concentrations were associated with amyloidotic CMP. Taken together, these results suggest that CLU may play a pathogenetic role in TTR and Ig light chain amyloidoses and amyloidotic CMP. Copyright Â
© 2011 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21224044      PMCID: PMC3070592          DOI: 10.1016/j.ajpath.2010.11.015

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  22 in total

Review 1.  Clusterin is a secreted mammalian chaperone.

Authors:  M R Wilson; S B Easterbrook-Smith
Journal:  Trends Biochem Sci       Date:  2000-03       Impact factor: 13.807

2.  Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings.

Authors:  R B Devereux; D R Alonso; E M Lutas; G J Gottlieb; E Campo; I Sachs; N Reichek
Journal:  Am J Cardiol       Date:  1986-02-15       Impact factor: 2.778

3.  Stress-induced transcription of the clusterin/apoJ gene.

Authors:  D Michel; G Chatelain; S North; G Brun
Journal:  Biochem J       Date:  1997-11-15       Impact factor: 3.857

4.  Amyloidogenic light chains induce cardiomyocyte contractile dysfunction and apoptosis via a non-canonical p38alpha MAPK pathway.

Authors:  Jianru Shi; Jian Guan; Bingbing Jiang; Daniel A Brenner; Federica Del Monte; Jennifer E Ward; Lawreen H Connors; Douglas B Sawyer; Marc J Semigran; Thomas E Macgillivray; David C Seldin; Rodney Falk; Ronglih Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2010-02-11       Impact factor: 11.205

5.  Apolipoprotein J/clusterin induction in myocarditis: A localized response gene to myocardial injury.

Authors:  D K Swertfeger; D P Witte; W D Stuart; H A Rockman; J A Harmony
Journal:  Am J Pathol       Date:  1996-06       Impact factor: 4.307

6.  Clusterin has chaperone-like activity similar to that of small heat shock proteins.

Authors:  D T Humphreys; J A Carver; S B Easterbrook-Smith; M R Wilson
Journal:  J Biol Chem       Date:  1999-03-12       Impact factor: 5.157

Review 7.  Amyloid heart disease. New frontiers and insights in pathophysiology, diagnosis, and management.

Authors:  Walid Hassan; Hani Al-Sergani; Walid Mourad; Rashed Tabbaa
Journal:  Tex Heart Inst J       Date:  2005

Review 8.  Clusterin: physiologic and pathophysiologic considerations.

Authors:  M E Rosenberg; J Silkensen
Journal:  Int J Biochem Cell Biol       Date:  1995-07       Impact factor: 5.085

9.  Apolipoprotein J expression at fluid-tissue interfaces: potential role in barrier cytoprotection.

Authors:  B J Aronow; S D Lund; T L Brown; J A Harmony; D P Witte
Journal:  Proc Natl Acad Sci U S A       Date:  1993-01-15       Impact factor: 11.205

10.  Human amyloidogenic light chains directly impair cardiomyocyte function through an increase in cellular oxidant stress.

Authors:  Daniel A Brenner; Mohit Jain; David R Pimentel; Bo Wang; Lawreen H Connors; Martha Skinner; Carl S Apstein; Ronglih Liao
Journal:  Circ Res       Date:  2004-03-25       Impact factor: 17.367

View more
  21 in total

1.  Increased serum free light chains precede the presentation of immunoglobulin light chain amyloidosis.

Authors:  Brendan M Weiss; Joseph Hebreo; Daniel V Cordaro; Mark J Roschewski; Thomas P Baker; Kevin C Abbott; Stephen W Olson
Journal:  J Clin Oncol       Date:  2014-07-14       Impact factor: 44.544

Review 2.  Current perspectives on cardiac amyloidosis.

Authors:  Jian Guan; Shikha Mishra; Rodney H Falk; Ronglih Liao
Journal:  Am J Physiol Heart Circ Physiol       Date:  2011-11-04       Impact factor: 4.733

3.  Regulating extracellular proteostasis capacity through the unfolded protein response.

Authors:  Joseph C Genereux; R Luke Wiseman
Journal:  Prion       Date:  2015       Impact factor: 3.931

4.  Effect of diflunisal on clusterin levels in ATTRwt amyloidosis.

Authors:  Celia Torres-Arancivia; Lawreen H Connors
Journal:  Amyloid       Date:  2019       Impact factor: 7.141

Review 5.  Recent advances in the noninvasive strategies of cardiac amyloidosis.

Authors:  Lei Zhao; Quan Fang
Journal:  Heart Fail Rev       Date:  2016-11       Impact factor: 4.214

6.  Detection of high-molecular-weight amyloid serum protein complexes using biological on-line tracer sedimentation.

Authors:  Jonathan S Kingsbury; Thomas M Laue; Susan F Chase; Lawreen H Connors
Journal:  Anal Biochem       Date:  2012-03-27       Impact factor: 3.365

7.  Transthyretin cardiac amyloidoses in older North Americans.

Authors:  Kumar Dharmarajan; Mathew S Maurer
Journal:  J Am Geriatr Soc       Date:  2012-02-13       Impact factor: 5.562

8.  Protective role of clusterin in preserving endothelial function in AL amyloidosis.

Authors:  Daniel A Franco; Seth Truran; Camelia Burciu; David D Gutterman; Anthony Maltagliati; Volkmar Weissig; Parameswaran Hari; Raymond Q Migrino
Journal:  Atherosclerosis       Date:  2012-09-01       Impact factor: 5.162

9.  A panel of protein candidates for comprehensive study of Caprine Arthritis Encephalitis (CAE) infection.

Authors:  Rosivaldo Quirino Bezerra Júnior; Ângela Maria Xavier Eloy; João Ricardo Furtado; Raymundo Rizaldo Pinheiro; Alice Andrioli; Frederico Bruno Moreno; Marina Duarte Pinto Lobo; Ana Cristina O Monteiro-Moreira; Renato de Azevedo Moreira; Tatiana Maria Farias Pinto; Maria Fátima da Silva Teixeira
Journal:  Trop Anim Health Prod       Date:  2017-10-12       Impact factor: 1.559

10.  Glycosylation of Serum Clusterin in Wild-Type Transthyretin-Associated (ATTRwt) Amyloidosis: A Study of Disease-Associated Compositional Features Using Mass Spectrometry Analyses.

Authors:  Celia M Torres-Arancivia; Deborah Chang; William E Hackett; Joseph Zaia; Lawreen H Connors
Journal:  Biochemistry       Date:  2020-11-03       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.